Dong-A Pharmaceutical Co.,Ltd. (KRX:000640)
South Korea flag South Korea · Delayed Price · Currency is KRW
88,500
-1,400 (-1.56%)
Nov 17, 2026, 3:30 PM KST

Dong-A Pharmaceutical Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Dong-A Pharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of ₩145,000. The average 1-year stock price forecast is 63.84% higher than the current stock price, while the lowest is ₩140,000 (+58.19%) and the highest is ₩150,000 (+69.49%).

Price Target: ₩145,000 (+63.84%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price₩140,000₩145,000₩145,000₩150,000
Change+58.19%+63.84%+63.84%+69.49%

Analyst Ratings

The average analyst rating for Dong-A Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingNov '25Mar '26Apr '26Jul '26Aug '26Oct '26
Strong Buy222222
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total333333

Financial Forecast

Revenue This Year
94.80B
from 1.43T
Decreased by -93.37%
Revenue Next Year
1.75T
from 94.80B
Increased by 1,746.77%
EPS This Year
11.21K
from 14.13K
Decreased by -20.64%
EPS Next Year
13.75K
from 11.21K
Increased by 22.61%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
881.94B1.01T1.13T1.33T1.43T94.80B
Revenue Growth
12.59%15.07%11.54%17.78%7.24%-93.37%
Operating Income
61.56B37.85B76.88B82.09B97.77B110.20B
Net Income
60.27B11.15B57.99B58.02B90.94B74.00B
EPS
----14,130.0011,214.00
EPS Growth
----56.80%-20.64%
Forward PE
12.539.958.669.976.197.89
Dividend / Share
--2,073.711,602.411,650.491,750.00
Dividend Growth
----22.73%3.00%6.03%
Free Cash Flow
----178.13B140.30B
No. Analysts
-----1
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.

Revenue Forecast

Revenue202620272028
High94.8B
Avg94.8B
Low94.8B

Revenue Growth

Revenue Growth202620272028
High
-93.4%
Avg
-93.4%
Low
-93.4%

EPS Forecast

EPS202620272028
High11,729.00
Avg11,214.00
Low10,932.00

EPS Growth

EPS Growth202620272028
High
-17.0%
Avg
-20.6%
Low
-22.6%